Sumiyah Al-houmaidy, | |
439 Sw Michigan St, Lake City, FL 32025-0440 | |
(352) 374-5600 | |
Not Available |
Full Name | Sumiyah Al-houmaidy |
---|---|
Gender | Female |
Speciality | Registered Nurse |
Location | 439 Sw Michigan St, Lake City, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053892224 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | RN9487206 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sumiyah Al-houmaidy, 4300 Sw 13th St, Gainesville, FL 32608-4006 Ph: (352) 374-5600 | Sumiyah Al-houmaidy, 439 Sw Michigan St, Lake City, FL 32025-0440 Ph: (352) 374-5600 |
News Archive
New data from the Phase III EMBRACA trial led by researchers at The University of Texas MD Anderson Cancer Center found the PARP inhibitor talazoparib did not demonstrate a statistically significant overall survival (OS) benefit for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.
An experimental vaccine composed of a genetically modified bacterium closely related to the bacterium that causes tuberculosis (TB) has been found to protect mice against TB infection, according to a study appearing online September 4 in the journal Nature Medicine.
Identifying gene mutations in cancer patients to predict clinical outcome has been the cornerstone of cancer research for nearly three decades, but now researchers at the Kimmel Cancer Center at Jefferson have invented a new approach that instead links cancer cell metabolism with poor clinical outcome. This approach can now be applied to virtually any type of human cancer cell.
Increased arterial stiffness is a known predictor of cardiovascular diseases in different populations, including healthy subjects and patients with hypertension, diabetes, or renal disease.
Data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tocilizumab monotherapy is more effective than adalimumab monotherapy in the treatment of rheumatoid arthritis (RA) based on change from baseline in DAS28 (-3.3 vs. -1.8, p<0.0001) at week 24.
› Verified 2 days ago
Mrs. Sharon Lynear Hayes, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 619 S Marion Ave, Lake City, FL 32025 Phone: 386-755-3016 | |
Kaitlin Drewing, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 439 Sw Michigan St, Lake City, FL 32025 Phone: 352-374-5600 | |
Rita Jean Sypitkowski, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 439 Sw Michigan St, Lake City, FL 32025 Phone: 386-487-0800 | |
Mrs. Jamee Lauri Douglas, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 185 Sw Curinton Ct, Lake City, FL 32024 Phone: 386-984-2764 | |
Angela Seay, APRN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 173 Nw Albritton Ln, Lake City, FL 32055 Phone: 386-755-4020 Fax: 386-758-9483 | |
Kaylee L Estevez, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 439 Sw Michigan St, Lake City, FL 32025 Phone: 352-374-5600 |